Day: February 5, 2020

Aytu BioScience Announces Acceptance of Results of Two Natesto Clinical Studies for Presentation at American Urological Association Annual Scientific Program

ENGLEWOOD, CO / ACCESSWIRE / February 5, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing...

Milestone Scientific Announces Abstract of CompuFlo(R) Epidural Instrument Integrated with CompuWave Technology Accepted for Presentation at Euroanaesthesia 2020 Congress

LIVINGSTON, NJ / ACCESSWIRE / February 5, 2020 / Milestone Scientific Inc. (NYSE:MLSS) today announced that an abstract, entitled "Confirmation...

AIM ImmunoTech Announces Completion of Third-Party Clinical Trial Using Ampligen in Combination with Other Therapies as Adjuvant Treatment of Peritoneal Surface Malignancies

OCALA, FL / ACCESSWIRE / February 5, 2020 / AIM ImmunoTech Inc. (NYSE American: AIM), an immuno-pharma company focused on the...

error: Content is protected !!